Shixone TZ 1000mg/125mg Injection
Marketer
Shivon Lifesciences Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Shixone TZ 1000mg/125mg Injection
TZ-Shixone 1000mg/125mg injectable solution is a dual-action antibiotic, indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby curbing infection spread. Administration must always be under a healthcare provider's direct guidance. Consistent adherence to the prescribed dosage schedule is crucial; completing the full course is vital, even with symptom improvement. Premature cessation may compromise treatment efficacy. Minor adverse reactions, including nausea, vomiting, diarrhea, and dyspepsia, are possible. Report any worsening side effects to your physician promptly. Seek immediate medical attention for allergic manifestations (e.g., skin rashes, pruritus, edema, respiratory distress). Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Sufficient rest, a nutritious diet, and ample hydration promote recovery. Your doctor may order laboratory and imaging studies to monitor treatment response.
Primary Ingredients of Shixone TZ 1000mg/125mg Injection
No information provided. Please provide the text you wish to be rephrased.
Uses of Shixone TZ 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Shixone TZ 1000mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Shixone TZ 1000mg/125mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Shixone TZ 1000mg/125mg Injection:
The medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
How Shixone TZ 1000mg/125mg Injection works:
Ceftriaxone and Tazobactum, combined as Shixone TZ 1000mg/125mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone's antibiotic properties disrupt bacterial cell wall synthesis, hindering their ability to survive. The addition of Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from using Shixone TZ 1000mg/125mg Injection concurrently with alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Shixone TZ (1000mg/125mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; however, data from human trials remains scarce.
Breast feedingCAUTION
Administering Shixone TZ 1000mg/125mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Shixone TZ 1000mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Shixone TZ 1000mg/125mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The injectable medication Shixone TZ (1000mg/125mg) requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Shixone TZ (1000mg/125mg) injection is not suggested for those with mild or moderate liver dysfunction.
What if you forget to take Shixone TZ 1000mg/125mg Injection :
Should you inadvertently omit a scheduled dose of Shixone TZ 1000mg/125mg Injection, seek medical advice from your physician.
Facts to Know About Shixone TZ 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
3,018 People bought this recently